Autolus Therapeutics Plc Asset Turnover Ratio (AUTL), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Autolus Therapeutics Plc  (NASDAQ: AUTL)
 

Autolus Therapeutics Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Autolus Therapeutics Plc asset turnover ratio, the ability of Autolus Therapeutics Plc's assets to generate revenue in the second quarter 2026, increased sequentially to 0.21 in the second quarter (Jun 30 2026), AUTL's balance sheet remain strong.

Within sector 37 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 2487, from total ranking in the first quarter 2026 at 2802.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AUTL Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -31.59 % -29.38 % -33.28 % -13.4 % -10.35 %
Y / Y Revenue Change 118.37 % 191.89 % 83655.17 % - -
Asset Turnover Ratio (TTM) 0.21 0.15 0.11 0.07 0.04
AUTL's Total Ranking # 2487 # 2802 # 3172 # 0 #
Seq. Asset Change -6.42 % -10.22 % -11.31 % -8.19 % -3.4 %
Seq. Revenue Change 74.27 % 7.94 % 14.6 % 1.3 % 132.94 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 38
Healthcare Sector # 414
Overall Market # 2487

Asset Turnover Ratio Statistics
High Average Low
0.15 0.06 0
(Mar 31 2026)   (Dec 31 2022)




AUTL Company Profile • Back to AUTL Efficiency Comparisons • Compare AUTL Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Anika Therapeutics Inc   0.65 $ 121.370  Millions$ 185.642  Millions
Agenus Inc  0.65 $ 132.693  Millions$ 204.959  Millions
Logicmark Inc  0.64 $ 12.544  Millions$ 19.555  Millions
Strata Critical Medical Inc   0.64 $ 211.642  Millions$ 330.217  Millions
Bridgebio Pharma Inc   0.63 $ 713.069  Millions$ 1,130.639  Millions
Ss Innovations International Inc  0.63 $ 52.199  Millions$ 82.833  Millions
Rigel Pharmaceuticals Inc  0.62 $ 276.785  Millions$ 445.451  Millions
Bioaffinity Technologies Inc   0.62 $ 5.901  Millions$ 9.518  Millions
Macrogenics Inc   0.61 $ 167.674  Millions$ 272.723  Millions
Heron Therapeutics Inc   0.60 $ 151.507  Millions$ 250.826  Millions
10x Genomics Inc   0.60 $ 616.566  Millions$ 1,028.638  Millions
Heartflow Inc   0.60 $ 210.791  Millions$ 353.085  Millions
Pacira Biosciences inc   0.60 $ 746.164  Millions$ 1,253.752  Millions
Conmed Corporation  0.59 $ 1,371.657  Millions$ 2,315.871  Millions
Radnet Inc   0.58 $ 2,268.932  Millions$ 3,883.896  Millions
Capsovision Inc   0.58 $ 12.804  Millions$ 22.085  Millions
Stereotaxis Inc   0.58 $ 29.892  Millions$ 51.863  Millions
Adaptive Biotechnologies Corporation  0.57 $ 308.081  Millions$ 537.492  Millions
Agilent Technologies inc   0.56 $ 7,372.000  Millions$ 13,121.500  Millions
Vsee Health Inc   0.56 $ 10.759  Millions$ 19.218  Millions
Intuitive Surgical Inc   0.56 $ 11,296.300  Millions$ 20,199.525  Millions
Vireo Growth Inc.  0.55 $ 511.706  Millions$ 924.643  Millions
Ceribell Inc   0.55 $ 101.804  Millions$ 184.939  Millions
Cormedix Inc   0.55 $ 451.943  Millions$ 824.173  Millions
Stryker Corp  0.55 $ 25,837.000  Millions$ 47,280.500  Millions
Transmedics Group Inc   0.54 $ 668.468  Millions$ 1,228.405  Millions
American Shared Hospital Services  0.54 $ 30.210  Millions$ 55.582  Millions
Integer Holdings Corporation  0.54 $ 1,842.621  Millions$ 3,410.801  Millions
Glaukos Corp  0.54 $ 500.031  Millions$ 926.678  Millions
Charles River Laboratories International inc   0.53 $ 3,998.987  Millions$ 7,477.922  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.